HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
GPI
glucose-6-phosphate isomerase
Chromosome 19 Β· 19q13.11
NCBI Gene: 2821Ensembl: ENSG00000105220.17HGNC: HGNC:4458UniProt: A0A2U3TZU2
220PubMed Papers
21Diseases
0Drugs
33Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
positive regulation of immunoglobulin productionglucose 6-phosphate metabolic processmembraneextracellular exosomehemolytic anemia due to glucophosphate isomerase deficiencyhereditary spherocytosishemolytic anemiagenetic disorder
✦AI Summary

GPI (glucose-6-phosphate isomerase) is a bifunctional enzyme with distinct intracellular and extracellular roles. Intracellularly, GPI catalyzes the reversible conversion of glucose-6-phosphate to fructose-6-phosphate, the second committed step of glycolysis and a key reaction in gluconeogenesis 1. The enzyme also exhibits C2-epimerase and anomerase activities on various hexose phosphates. Beyond its metabolic function, GPI operates as a secreted cytokine with multiple immunological and angiogenic properties. It functions as autocrine motility factor (AMF), enhancing endothelial cell motility and angiogenesis 2. GPI also acts as neuroleukin, a neurotrophic factor supporting spinal and sensory neuron survival 34. When released by lectin-stimulated T cells, GPI induces immunoglobulin secretion, contributing to humoral immune responses 34. GPI deficiency causes congenital non-spherocytic hemolytic anemia type 4, highlighting the critical importance of glycolytic flux for erythrocyte survival. The dual functionality of GPIβ€”combining essential metabolic activity with cytokine-like immunomodulatory propertiesβ€”represents a unique example of a housekeeping enzyme serving systemic regulatory roles.

Sources cited
1
GPI catalyzes conversion of glucose-6-phosphate to fructose-6-phosphate in glycolysis and gluconeogenesis
PMID: 28803808
2
GPI functions extracellularly as autocrine motility factor (AMF), enhancing endothelial cell motility
PMID: 11437381
3
GPI functions as neuroleukin supporting neuron survival and is released by T cells to induce immunoglobulin secretion
PMID: 11004567
4
GPI acts as neurotrophic factor for neurons and functions in immunoglobulin production by T cells
PMID: 3352745
⚠Limited data available β€” This gene has 4 indexed publications. Summary and analysis may be incomplete.
Disease Associationsβ“˜21
hemolytic anemia due to glucophosphate isomerase deficiencyOpen Targets
0.83Strong
hereditary spherocytosisOpen Targets
0.28Weak
hemolytic anemiaOpen Targets
0.26Weak
genetic disorderOpen Targets
0.19Weak
autosomal recessive non-syndromic intellectual disabilityOpen Targets
0.12Weak
gastric cancerOpen Targets
0.10Suggestive
rheumatoid arthritisOpen Targets
0.09Suggestive
lung adenocarcinomaOpen Targets
0.08Suggestive
Adult-onset autosomal recessive sideroblastic anemiaOpen Targets
0.07Suggestive
dehydrated hereditary stomatocytosisOpen Targets
0.06Suggestive
Congenital dyserythropoietic anemia type IOpen Targets
0.06Suggestive
arthritisOpen Targets
0.06Suggestive
diffuse large B-cell lymphomaOpen Targets
0.06Suggestive
Hemolytic anemia due to red cell pyruvate kinase deficiencyOpen Targets
0.06Suggestive
sideroblastic anemia 3Open Targets
0.06Suggestive
malariaOpen Targets
0.06Suggestive
congenital dyserythropoietic anemia type 4Open Targets
0.06Suggestive
Congenital dyserythropoietic anemia type IVOpen Targets
0.06Suggestive
hemoglobin D diseaseOpen Targets
0.06Suggestive
beta-thalassemia-X-linked thrombocytopenia syndromeOpen Targets
0.06Suggestive
Anemia, congenital, non-spherocytic hemolytic, 4UniProt
Pathogenic Variants33
NM_000175.5(GPI):c.1039C>T (p.Arg347Cys)Pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 347
NM_000175.5(GPI):c.244del (p.Glu82fs)Pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 82
NM_000175.5(GPI):c.1009G>A (p.Ala337Thr)Pathogenic
not provided|Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜…β˜†β˜†2024β†’ Residue 337
NM_000175.5(GPI):c.1040G>A (p.Arg347His)Pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜…β˜†β˜†2023β†’ Residue 347
NM_000175.5(GPI):c.286C>T (p.Arg96Ter)Pathogenic
not provided|Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜…β˜†β˜†2021β†’ Residue 96
NM_000175.5(GPI):c.1414C>T (p.Arg472Cys)Pathogenic
not provided|Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜…β˜†β˜†2021β†’ Residue 472
NM_000175.5(GPI):c.1336C>T (p.Arg446Ter)Pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜…β˜†β˜†2019β†’ Residue 446
NM_000175.5(GPI):c.259G>T (p.Gly87Cys)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 87
NM_000175.5(GPI):c.1028A>G (p.Gln343Arg)Pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency|not provided|Thyroid cancer, nonmedullary, 1
β˜…β˜†β˜†β˜†2025β†’ Residue 343
NM_000175.5(GPI):c.1140G>A (p.Trp380Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 380
NM_000175.5(GPI):c.1010C>T (p.Ala337Val)Pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜†β˜†β˜†2025β†’ Residue 337
NM_000175.5(GPI):c.838A>G (p.Ile280Val)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 280
NM_000175.5(GPI):c.1162del (p.Gln388fs)Likely pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜†β˜†β˜†2024β†’ Residue 388
NM_000175.5(GPI):c.833C>T (p.Ser278Leu)Likely pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜†β˜†β˜†2024β†’ Residue 278
NM_000175.5(GPI):c.1475-2A>GLikely pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜†β˜†β˜†2024
NM_000175.5(GPI):c.866-1G>ALikely pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜†β˜†β˜†2023
NM_000175.5(GPI):c.937_952dup (p.Val318fs)Likely pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜†β˜†β˜†2023β†’ Residue 318
NM_000175.5(GPI):c.283-2A>GLikely pathogenic
Hereditary spherocytosis
β˜…β˜†β˜†β˜†2023
NM_000175.5(GPI):c.48dup (p.Tyr17fs)Likely pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜†β˜†β˜†2023β†’ Residue 17
NM_000175.5(GPI):c.1269+1G>ALikely pathogenic
Hemolytic anemia due to glucophosphate isomerase deficiency
β˜…β˜†β˜†β˜†2023
View on ClinVar β†—
Related Genes
ENO1Protein interaction100%PGDProtein interaction100%RPEProtein interaction100%PRDX6Protein interaction100%RPIAProtein interaction100%PARP6Protein interaction100%
Tissue Expression6 tissues
Heart
100%
Bone Marrow
66%
Brain
65%
Liver
59%
Lung
30%
Ovary
28%
Gene Interaction Network
Click a node to explore
GPIENO1PGDRPEPRDX6RPIAPARP6
PROTEIN STRUCTURE
Preparing viewer…
PDB9FCW Β· 1.40 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.86LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.67 [0.53–0.86]
RankingsWhere GPI stands among ~20K protein-coding genes
  • #1,869of 20,598
    Most Researched220 Β· top 10%
  • #1,717of 5,498
    Most Pathogenic Variants33
  • #7,540of 17,882
    Most Constrained (LOEUF)0.86
Genes detectedGPI
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Biosynthesis and biology of mammalian GPI-anchored proteins.
PMID: 32156170
Open Biol Β· 2020
1.00
2
Glycosyl-phosphatidylinositol-anchored membrane proteins.
PMID: 1450366
J Am Soc Nephrol Β· 1992
0.90
3
Cripto-1 in TNBC.
PMID: 26298547
Aging (Albany NY) Β· 2015
0.80
4
Non-HFE hemochromatosis.
PMID: 14752817
Hepatology Β· 2004
0.70
5
Glycosylphosphatidylinositol biosynthesis functions as a conserved host defense pathway against coronaviruses via regulation of LY6E.
PMID: 40901862
PLoS Pathog Β· 2025
0.68